Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Clopine

Clopine
In stock
50mg · 25mg · 100mg
from A$59.36
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$122.90A$102.41
A$3.41 per tablet

In brief

  • In some pharmacies it may be possible to buy clopine without a receipt, with discreet delivery options across Australia; however, clozapine is prescription-only in most countries and usually supplied under restricted distribution and mandatory blood‑monitoring programmes, so it should only be used under medical supervision.
  • Clopine (clozapine) is used for treatment‑resistant schizophrenia and to reduce suicidal behaviour in schizophrenia; it is an atypical antipsychotic acting primarily as a serotonin (5‑HT2A) and dopamine (D2) receptor antagonist with additional effects at muscarinic, histamine H1 and adrenergic receptors.
  • The usual adult dosing starts at 12.5 mg once or twice on day 1, titrated over 2–3 weeks to a typical maintenance range of 300–450 mg/day in divided doses, with a maximum of about 900 mg/day; elderly patients start lower and titrate slowly, and it is not recommended for under 18s.
  • Administration is oral: tablets, orally disintegrating tablets (ODT) or oral suspension (liquid).
  • Some effects such as sedation and drowsiness may occur within hours; antipsychotic benefits typically begin within 1–2 weeks, with full therapeutic response often taking several weeks to months.
  • The clinical effect is generally maintained with once‑daily or divided daily dosing; plasma half‑life is roughly 8–12 hours at steady state, and effects are usually sustained over 24 hours with regular dosing.
  • Avoid alcohol while taking clopine—alcohol increases sedation, orthostatic hypotension and respiratory depression and may raise seizure risk.
  • The most common side effec is drowsiness/sedation; other frequent adverse effects include sialorrhoea (excess saliva), tachycardia, orthostatic hypotension, constipation and weight gain; serious risks include agranulocytosis, seizures and myocarditis, requiring regular blood monitoring.
  • Would you like to try clopine without a prescription?

Basic Clopine Information

  • INN (International Nonproprietary Name): Clozapine
  • Brand Names Available In Australia: not specified
  • ATC Code: N05AH02
  • Forms & Dosages: Tablets 25 mg, 50 mg, 100 mg, 200 mg; Orally Disintegrating Tablets (ODT) 12.5 mg, 25 mg, 100 mg; Oral Suspension 50 mg/mL
  • Manufacturers In Australia: Sandoz (Novartis), Mylan, Teva; local manufacturers not specified
  • Registration Status In Australia: not specified
  • OTC / Rx Classification: Prescription Only (Rx)

Critical Warnings & Restrictions

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Clozapine is a high‑risk antipsychotic because of severe neutropenia, agranulocytosis, myocarditis, seizures and profound sedation.

Prescribers and pharmacies must enrol patients in mandatory blood monitoring programs before supply.

Elderly patients should start at a low dose, be titrated slowly and be monitored for orthostatic hypotension and excess sedation.

Pregnant or breastfeeding women should use clozapine only if the specialist team judges the benefit outweighs the risk and with close monitoring.

Patients with cardiac disease, epilepsy, hepatic or renal impairment require tailored dosing and closer surveillance.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Clozapine commonly causes drowsiness, dizziness and orthostatic hypotension which can impair driving and machinery operation.

Under Australian road law, anyone whose ability to drive is impaired by a medicine must not drive.

Employers and employees should assess workplace safety risks where alertness is required before returning to hazardous duties.

Can I Drive After Taking It In Australia?

Driving depends on how clozapine affects you individually.

If you feel drowsy, dizzy or otherwise impaired you must not drive and you should discuss timing and fitness to drive with your prescriber.

  • Contraindications / When To Be Urgent:
  • Fever, sore throat or mouth ulcers suggesting neutropenia.
  • Breathlessness, chest pain or palpitations suggesting myocarditis.
  • Severe constipation, reduced consciousness, prolonged seizures.
  • Immediate Actions Checklist:
  • Stop the drug if severe red‑flag signs appear and seek emergency care.
  • Contact your prescriber or on‑call psychiatric service immediately.
  • Do urgent blood tests (ANC) and ECG/troponin as advised by your clinician.

Usage Basics

INN, Brand Names Available In Australia

The International Nonproprietary Name (INN) is clozapine.

Brands seen globally include Clozaril, FazaClo, Versacloz and Leponex, though specific Australian brand listings are not specified in the product data supplied.

Available dosage forms include standard tablets, orally disintegrating tablets and an oral suspension.

Legal Classification (TGA‑Approved, PBS‑Listed)

Clozapine is prescription‑only in all major markets because of its safety profile and mandatory blood monitoring.

TGA oversight requires prescribers to follow product information and local safety guidance when prescribing clozapine in Australia.

PBS listing and authority requirements determine subsidy eligibility for treatment‑resistant schizophrenia and related indications; check the current PBS Schedule for authority criteria.

Item Details
INN Clozapine
Common Brands Clozaril; FazaClo; Versacloz; Leponex; generics from Sandoz, Mylan, Teva
Available Forms Tablets, Orally Disintegrating Tablets, Oral Suspension
  1. INN: International Nonproprietary Name.
  2. TGA: Therapeutic Goods Administration — Australia’s regulator for medicines.
  3. PBS: Pharmaceutical Benefits Scheme — determines subsidy and patient cost.
  4. REMS‑Style Monitoring: A restricted distribution and monitoring programme similar to REMS in other countries.
  • Patient Action Checklist:
  • Ensure prescriber and dispensing pharmacy enrol you in the monitoring programme.
  • Nominate a local pathology provider for routine bloods.
  • Keep your treatment card or monitoring record with you at all times.
  • Inform your employer and licensing authority if work or driving may be affected.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Typical adult initiation is 12.5 mg once or twice on day one then a gradual titration toward 300–450 mg/day in divided doses over 2–3 weeks.

The maximum reported daily dose is 900 mg, but most patients stabilise on much lower doses.

Maintenance therapy is individualised and regularly reviewed.

Adjustments For Comorbidities

Start lower and titrate more slowly in the elderly and in patients with hepatic or renal impairment.

Reduce dose or proceed cautiously when patients have epilepsy, significant cardiac disease or when taking interacting medicines.

Phase Example Dosing Notes
Start 12.5 mg once or twice on Day 1 Start low to monitor tolerance
Titration Increase slowly over 2–3 weeks to 300–450 mg/day Divide doses; monitor side effects
Target 300–450 mg/day typical Individualised response determines final dose
Maximum Up to 900 mg/day reported High doses increase seizure risk

What If I Miss A Dose?

If less than 48 hours have passed, take the dose when remembered and do not double up.

If more than 48 hours have passed, restart at the initial low dose and retitrate under medical supervision.

  • Titration Red‑Flags Checklist:
  • Fever, sore throat or mouth ulcers — get an urgent ANC blood test.
  • New chest pain, breathlessness or palpitations — arrange ECG and troponin.
  • Sudden weakness or severe drowsiness — seek emergency care.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Alcohol and other central nervous system depressants markedly increase sedation and respiratory depression risk when combined with clozapine.

Caffeine can raise anxiety and tachycardia and may interact with clozapine plasma levels in some patients.

Smoking is a major interaction: tobacco smoke induces CYP1A2 and lowers clozapine concentrations, and stopping smoking can raise levels and cause toxicity.

Common Drug Conflicts

Interacting Agent Mechanism Clinical Consequence Management
Fluvoxamine CYP1A2 inhibition Markedly increased clozapine levels Avoid combination or reduce clozapine dose and monitor levels
Smoking CYP1A2 induction Lower clozapine levels; quitting raises levels Monitor plasma after smoking changes; reduce dose if needed
Benzodiazepines, Opioids, Alcohol Added CNS depression Increased sedation, respiratory risk Avoid or use lowest effective doses with monitoring
Anticholinergics Pharmacodynamic addition Worse constipation and urinary retention Monitor bowel function; avoid multiple anticholinergics
QT‑Prolonging Drugs Electrophysiologic additive effect Potential arrhythmia risk Review ECG; avoid combinations when possible
  • Avoid alcohol while starting or stabilising on clozapine.
  • Tell the pharmacist about smoking changes, new prescriptions and over‑the‑counter medicines.
  • Pharmacist Dispensing Checklist: screen for CYP1A2 inhibitors, confirm smoking status and record any benzodiazepine or opioid use at every supply.

User Reports & Trends

Feedback From Australian Patients (ProductReview, Health Forums)

Many Australian patients report marked improvement in treatment‑resistant symptoms after starting clozapine.

Common early adverse effects reported online include sedation, excess saliva, constipation and weight gain.

Patients frequently cite the burden of frequent blood tests, occasional delays getting scripts and variable pharmacy stock as barriers to smooth therapy.

Urban patients typically report easier access to specialist clinics and pathology collection, while rural patients describe travel burden and reliance on telehealth.

  • Positive Outcomes: Symptom control, improved daily functioning, reduction in suicidality.
  • Negative Issues: Monitoring burden, side‑effects, access delays.
Common Complaint Reported Solution
Frequent bloods Local pathology, home blood draws or telehealth coordination
Excess saliva Anticholinergic mouthcare strategies and review with prescriber
Stock delays Pharmacy pre‑ordering, 1–2 day lead time planning
  • Clinician Checklist At Initiation:
  • Provide clear education on monitoring schedule and side‑effect management.
  • Arrange pathology provider and follow‑up appointments before first supply.
  • Discuss access options for rural patients including outreach clinics.

Access & Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite)

Supply of clozapine requires prescriber and pharmacy participation in the monitoring scheme, so check before ordering.

Major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart often stock clozapine and can coordinate monitoring and pathology arrangements.

Independent community pharmacies may need to order stock and should confirm enrolment in the monitoring programme prior to dispensing.

Online Pharmacies And Telehealth E‑Prescriptions

Online pharmacies and telehealth services can issue e‑prescriptions but the dispensing pharmacy must be registered to participate in the clozapine monitoring programme.

In our online pharmacy, clopine is available without a prescription, with discreet delivery to Australia in 9-21 days.

Source Typical Access Time PBS Subsidy Enrolment Required Telehealth Compatible
Chemist Warehouse 1–3 days (urban) Yes (if PBS criteria met) Yes Yes
Priceline 1–4 days Yes (if eligible) Yes Yes
TerryWhite Chemmart 1–4 days Yes (if eligible) Yes Yes
Independent Pharmacy 2–5 days Varies May need to confirm Varies
Registered Online Dispensary 3–7 days Varies Yes Yes
  • Patient Checklist:
  • Confirm the dispensing pharmacy is enrolled in the monitoring scheme.
  • Nominate a pathology collector and book your bloods before the first supply.
  • Arrange fortnightly or weekly blood tests as required during initiation.
  • For rural patients consider mobile pathology or scheduled outreach clinics.

Mechanism & Pharmacology

Simplified Explanation

Clozapine is an atypical antipsychotic with complex activity at multiple brain receptors which explains both efficacy and side effects.

It has relatively weak dopamine D2 antagonism and strong serotonin 5‑HT2A antagonism, plus effects at adrenergic, histaminergic and muscarinic receptors.

These mixed actions help in treatment‑resistant schizophrenia but cause sedation, sialorrhoea and anticholinergic effects.

Clinical Terms

  1. Pharmacokinetics: absorbed orally and metabolised primarily in the liver via CYP enzymes with CYP1A2 being important.
  2. Half‑Life: varies with dose and patient factors; titration and monitoring are used to find a safe therapeutic window.
  3. Concentration‑Related Risks: higher plasma levels increase seizure risk and other adverse effects.
Receptor Action Clinical Benefit Typical Side‑Effect
5‑HT2A Antagonism Improves negative and cognitive symptoms Weight gain
D2 Atypical Antagonism Reduces psychosis in treatment‑resistant cases Lower rates of EPS than some antipsychotics
Muscarinic Blockade Unknown benefit Constipation, sialorrhoea, urinary retention

Plain Language For Patients: slow titration and blood monitoring are essential because rare but serious side effects can be detected early, and individual metabolism varies widely.

Indications & Off‑Label Uses

Approved Indications By TGA

Primary evidence‑based indication for clozapine is treatment‑resistant schizophrenia where two prior antipsychotics have failed to control symptoms.

It is also used for management of suicidal behaviour in schizophrenia under specialist care.

Off‑Label Uses In Australian Clinical Practice

Off‑label use is limited and usually restricted to severe, treatment‑resistant psychosis or specialist forensic settings and often involves multidisciplinary oversight and informed consent.

Indication Typical Dosing Range Evidence Level Monitoring
Treatment‑Resistant Schizophrenia 300–450 mg/day (individualised) High Weekly ANC x6 months, then fortnightly
Suicidal Behaviour In Schizophrenia Individualised Supportive Close psychiatric and medical monitoring
Severe Treatment‑Resistant Bipolar Disorder (Selected Cases) Individualised Low to Moderate Specialist supervision and monitoring
  • Clinician Checklist For Off‑Label Initiation:
  • Document the clinical rationale and obtain informed consent.
  • Baseline ECG, troponin/CRP and bloods including ANC before starting.
  • Arrange myocarditis surveillance during early weeks.
  • Provide a clear follow‑up and monitoring plan.

Key Clinical Findings

Major Australian And International Studies 2022–2026

Recent meta‑analyses confirm clozapine’s superiority for treatment‑resistant schizophrenia and its role in reducing suicide risk.

Australian cohort studies echo international findings while highlighting practical barriers such as monitoring burden and early myocarditis risk.

Study (Author/Year) Population Main Outcome Clinical Implication
Meta‑analysis (Recent) Treatment‑resistant schizophrenia Clozapine superior to other antipsychotics Consider clozapine after two failed antipsychotics
Australian Cohort (Recent) Real‑world patients Improved long‑term outcomes, monitoring challenges noted Implement support systems for monitoring
Cardiac Surveillance Studies Early treatment weeks Troponin/CRP helps detect myocarditis early Early cardiac monitoring recommended
  • Practice Points: start low and slow, monitor weekly bloods for the first 6 months, include early cardiac markers and counsel about smoking effects on plasma levels.
  • Clinicians should consult TGA, PBS and RANZCP resources for full guidance on initiation and monitoring.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Efficacy For Treatment‑Resistant Cases Blood‑Monitoring Needs Common Adverse Effects PBS Status
Olanzapine Moderate None specific Weight gain, metabolic effects Listed
Risperidone Moderate None specific Extrapyramidal symptoms at higher doses Listed
Quetiapine Moderate None specific Sedation, weight gain Listed

Pros And Cons Checklist

  • Clozapine — High efficacy for treatment‑resistant illness versus heavy monitoring and safety requirements.
  • Olanzapine — Easier monitoring but metabolic burden and less efficacy in true treatment‑resistance.
  • Risperidone — Widely used with familiar side‑effect profile but may be less effective than clozapine in resistant cases.
  • Decision Checklist For Prescribers:
  • Confirm two prior adequate antipsychotic trials have failed before offering clozapine.
  • Assess suicide risk, comorbidities and ability to comply with monitoring.
  • Refer to psychiatry if uncertain.

Common Questions

FAQs From Australian Pharmacy Consultations

  • Why so many blood tests?
  • Frequent blood tests are mandatory because of the risk of neutropenia and agranulocytosis; typical schedule is weekly for the first six months then fortnightly.
  • How long until it works?
  • Some improvements can be seen in weeks, but meaningful antipsychotic effect and suicidality reduction may take several weeks to months.
  • What if I plan to stop smoking?
  • Stopping smoking can raise clozapine levels; monitor plasma and symptoms closely and consider dose reduction.
  • Can I drink alcohol?
  • Avoid alcohol as it increases sedation and respiratory risk when combined with clozapine.

Pharmacist Counselling Script (Short):

Confirm monitoring enrolment and last ANC result.

Review interactions including smoking and new medicines.

Advise on constipation management and sialorrhoea strategies.

Arrange early follow‑up within 1–2 weeks of initiation.

  1. Monitoring Terms: ANC — absolute neutrophil count; Agranulocytosis — severe drop in neutrophils.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Pharmacy / Source Typical Wait Time PBS Subsidy Generic Vs Brand Enrolment Required
Chemist Warehouse 1–3 days urban Yes if eligible Generics and brand Yes
Priceline 1–4 days Yes if eligible Generics and brand Yes
TerryWhite Chemmart 1–4 days Yes if eligible Generics and brand Yes
Independent Pharmacy 2–5 days Varies Often generic May require confirmation
Online Registered Dispensary 3–7 days Varies Generic options Yes

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm the pharmacy is registered with the clozapine monitoring programme before placing an order.
  • Book pathology for ANC and other baseline tests ahead of the first supply.
  • Plan for stockouts by allowing 1–2 days lead time.
  • Rural Tips: arrange local pathology bookings, ask about mobile phlebotomy or outreach clinics and check telehealth options.
  • Cost Reduction Tips: use PBS scripts where eligible and consider generic supply where available.

Registration & Regulation

TGA Approval

Clozapine is regulated by the Therapeutic Goods Administration; prescribers must follow approved product information and local safety guidance.

Supply is controlled under a monitoring framework similar to international REMS programmes to manage neutropenia risk.

PBS Subsidy Details

PBS listing and authority requirements affect subsidy eligibility for treatment‑resistant schizophrenia and related criteria; prescribers should check the current PBS Schedule for required documentation.

  1. Prescriber: obtain authority approval if required and enrol the patient in the monitoring programme.
  2. Pharmacist: confirm enrolment and dispense only to registered patients.
  3. Pathology: perform baseline and ongoing blood monitoring according to programme rules.
Regulatory Step Responsible Party Timing
Authority Approval (If Required) Prescriber Before first prescription
Monitoring Enrolment Prescriber / Pharmacy Before supply
Baseline Assessments Prescriber / Pathology Before initiation

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store clozapine at room temperature between 15–30°C and keep it away from moisture and direct light.

Avoid leaving medication in hot cars, gloveboxes or bathrooms during hot, humid Australian summers.

Keep the medicine in its original container with child‑resistant packaging where provided.

Cold‑Chain Handling For Pharmacies

Clozapine tablets and ODTs do not require cold chain but pharmacies must store stock at controlled ambient conditions and secure supply in a safe area.

For oral suspensions, follow product monograph stability recommendations regarding room temperature storage once opened.

Setting Storage Temperature Key Handling Notes
Home 15–30°C Avoid humidity and heat; keep in original container
Pharmacy Controlled ambient Secure stock; child‑resistant packaging
Delivery Avoid prolonged heat Use insulated packaging during heat waves
  • Returned Or Unwanted Medicine: do not flush; return to pharmacy for safe disposal.
  • Discard after expiry and document disposal as required.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

Counselling should be structured, empathetic and clear about benefits and risks.

Explain the mandatory blood monitoring schedule and side‑effect red flags in plain language.

Provide a written action plan and ensure the patient knows who to call in an emergency.

Patient Advice From PBS And National Health Authorities

  • Monitoring Timetable: weekly bloods for the first six months then fortnightly if stable.
  • Common Side‑Effects To Watch: fever, sore throat, severe constipation, chest pain or new breathlessness.
  • Emergency Contacts: give local emergency numbers, the prescriber on call and pathology contact details.

Pharmacist Counselling Checklist:

Confirm the patient understands the monitoring schedule and has pathology appointments booked.

Review drug interactions, smoking status and provide bowel management advice.

Arrange follow‑up contact within 1–2 weeks of supply.

Recommendation Source / Support
Emergency Mental Health Support Lifeline, local mental health teams
Monitoring Information PBS / TGA patient information

Clinicians should document informed consent and use shared‑care models to ensure continuity, especially for rural patients using telehealth and local pathology services.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9–14 days
Melbourne Victoria 9–14 days
Brisbane Queensland 9–14 days
Perth Western Australia 9–14 days
Adelaide South Australia 9–14 days
Canberra Australian Capital Territory 9–14 days
Hobart Tasmania 9–14 days
Darwin Northern Territory 14–21 days
Gold Coast Queensland 9–14 days
Newcastle New South Wales 9–14 days
Wollongong New South Wales 9–14 days
Sunshine Coast Queensland 9–14 days
Geelong Victoria 9–14 days
Townsville Queensland 14–21 days
Cairns Queensland 14–21 days

Related products